PERP通过ATF3-HSPA6信号通路抑制乳腺癌转移
Caiping Chen1, Chao Han1, Li Xue1
1Affiliated Hospital of Jiaxing University (First Hospital of Jiaxing), China.
The Journal of international medical research
|December 28, 2025
概括
瘤抑制剂PERP (与PMP-22相关的p53亡效应物) 抑制了乳腺癌转移. 它通过增加ATF3来实现这一目标,然后激活HSPA6,为转移性乳腺癌提供了一个新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 与乳腺癌转移中与PMP-22 (PERP) 相关的瘤抑制剂p53亡效应物的功能尚不清楚.
- 了解PERP的作用对于开发针对转移性乳腺癌的新治疗策略至关重要.
研究的目的:
- 研究PERP在乳腺癌转移中的作用.
- 阐明PERP功能的临床意义和潜在的分子机制.
- 在转移性乳腺癌中确定潜在的治疗点.
主要方法:
- 在细胞系,公共数据集和患者样本中通过RT-qPCR,西部涂抹和免疫组织化学进行PERP表达分析.
- 在PERP操纵后的体外和体外转移测定 (过度表达/敲击).
- 使用siRNA,RNA测序,西部涂抹,RT-qPCR和ChIP评估ATF3和HSPA6的作用.
主要成果:
- 与正常对照组相比,PERP表达在乳腺癌组织和细胞系中明显较低.
- 低PERP水平与患者预后不佳相关,PERP过度表达抑制了转移.
- PERP上调调节ATF3,该ATF3与HSPA6促进体结合,激活其转录,从而调节PERP的抗转移作用.
结论:
- PERP通过PERP-ATF3-HSPA6信号轴抑制乳腺癌转移.
- ATF3诱导和随后的HSPA6激活是PERP抑制转移的关键机制.
- PERP-ATF3-HSPA6通路为治疗转移性乳腺癌提供了一个有前途的治疗标.
更多相关视频
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
11.5K
07:35A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
42.5K
相关概念视频
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
